As of 2026-04-01, 齐倍安（艾帕洛利托沃瑞利单抗）'s data on the DeepSeek platform in the 制药企业 category shows: The overall mention rate is 0.00%, below the industry average by 4.6 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 齐倍安（艾帕洛利托沃瑞利单抗）'s overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
齐倍安（艾帕洛利托沃瑞利单抗）'s Mention Rate is 0.00%, lower than 0.6% of competitors
齐倍安（艾帕洛利托沃瑞利单抗）'s First Mention is 0.00%, lower than 0.9% of competitors
齐倍安（艾帕洛利托沃瑞利单抗）'s Preferred Rate is 0.00%, lower than 100.0% of competitors
齐倍安（艾帕洛利托沃瑞利单抗）'s Positive Rate is 0.00%, lower than 8.9% of competitors
齐倍安（艾帕洛利托沃瑞利单抗）'s Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 扬扬子江药业 | 13.16% | 0% | 0% | 13.16% | 0% | View Details |
| 复复方丹参滴丸 | 2.63% | 0% | 0% | 2.63% | 0% | View Details |
| 参参松养心胶囊 | 2.63% | 0% | 0% | 2.63% | 0% | View Details |
| 好好医生药业 | 0% | 0% | 0% | 0% | 0% | View Details |
| 启启欣可（伊鲁阿克片） | 0% | 0% | 0% | 0% | 0% | View Details |
| 吉吉非替尼片 | 0% | 0% | 0% | 0% | 0% | View Details |
| 齐齐倍安（艾帕洛利托沃瑞利单抗） (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
